Press releases
- Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
- Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
- Theravance Biopharma to Participate in an Upcoming Investor Conference
- Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Key statistics
On Tuesday, Theravance Biopharma Inc (0TB:DUS) closed at 9.15, -13.68% below its 52-week high of 10.60, set on Jan 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.20 |
---|---|
High | 9.30 |
Low | 9.15 |
Bid | -- |
Offer | -- |
Previous close | 9.15 |
Average volume | 0.00 |
---|---|
Shares outstanding | 48.63m |
Free float | 45.67m |
P/E (TTM) | -- |
Market cap | 498.00m USD |
EPS (TTM) | -0.861 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 18:30 BST.
More ▼